Skip to main content

Advertisement

SpringerLink
Log in

Antiphospholipid Syndrome and Cognition

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

In addition to the well-defined neurologic events due to arterial and venous thrombotic vascular occlusions of antiphospholipid syndrome (APS), a broad spectrum of neuropsychiatric has been related to antiphospholipid (aPL). Experimental evidence of a pathogenic role of aPL in mice with impaired neurological function disclosed inflammatory reaction as a hallmark. The process that leads to neurological dysfunction seems to be both structurally destructive and functionally impairing. The most modern resources of neuroimmaging also suggest that, in addition to the micro-infarcts that occur in strategic areas, other metabolic impairments are related to progressive dementia and aPL presence. Although there is a lot of confusion among APS and lupus’ cognitive involvement, there is a body of experimental and clinical evidence that aPL causes this kind of damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sanna G, Bertolaccini ML, Cuadrado MJ et al (2003) Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 42:200–213

    Article  PubMed  CAS  Google Scholar 

  2. Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD (1997) Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 100(3):613–619

    Article  PubMed  CAS  Google Scholar 

  3. Hess DC, Taormina M, Thompson J et al (1993) Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 20(4):610–617

    PubMed  CAS  Google Scholar 

  4. Shoenfeld Y, Nahum A, Korczyn AD et al (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436–442

    Article  PubMed  CAS  Google Scholar 

  5. Caronti B, Pittoni V, Palladini G, Valesini G (1998) Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156(2):211–219

    Article  PubMed  CAS  Google Scholar 

  6. Caronti B, Calderaro C, Alessandri C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11(5):425–429

    Article  PubMed  CAS  Google Scholar 

  7. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD (1999) Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8(2):127–133

    Article  PubMed  CAS  Google Scholar 

  8. Cimaz R, Meroni PL, Shoenfeld Y (2006) Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughe’s syndrome). Lupus 15(4):191–197

    Article  PubMed  CAS  Google Scholar 

  9. Chinn RJ, Wilkinson ID, Hall-Craggs MA et al (1997) Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40(1):36–46

    Article  PubMed  CAS  Google Scholar 

  10. Kozora E, West SG, Kotzin BL et al (1998) Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 41(1):41–47

    Article  PubMed  CAS  Google Scholar 

  11. Hilker R, Thiel A, Geisen C, Rudolf J (2000) Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. Lupus 9(4):311–316

    Article  PubMed  CAS  Google Scholar 

  12. Sibbitt WL Jr, Haseler LJ, Griffey RR et al Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. Am J Neuroradiol YEAR 18:1271–1277

  13. Sabet A, Sibbitt WL Jr, Stidley CA et al (1998) Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 29:2254–2260

    PubMed  CAS  Google Scholar 

  14. Kozora E, Arciniegas DB, Filley CM et al (2005) Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 18(3):159–162

    Article  PubMed  Google Scholar 

  15. Appenzeller S, Li LM, Costallat L, Cendes F (2005) Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. Brain 128(12):2933–2940

    Article  PubMed  Google Scholar 

  16. Castellino G, Govoni M, Padovan M et al (2005) Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 64:1022–1027

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology, Rede D’Or de Hospitais, Rio de Janeiro, Brazil

    Bernardo Liberato

  2. Discipline of Rheumatology, Universidade do Estado do Rio de Janeiro, Hospital Pró-cardíaco, Rio de Janeiro, Brazil

    Roger A. Levy

  3. Diagnósticos da América SA, Av. Juruá, 434, Barueri—SPI, Brazil

    Roger A. Levy

Authors
  1. Bernardo Liberato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger A. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger A. Levy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liberato, B., Levy, R.A. Antiphospholipid Syndrome and Cognition. Clinic Rev Allerg Immunol 32, 188–191 (2007). https://doi.org/10.1007/s12016-007-0007-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-007-0007-x

Keywords

Search

Navigation